دورية أكاديمية
1460P IO-Synthesise RCC: Analysis of real-world (RW) health-related quality of life (HRQoL) outcomes with nivolumab for previously treated metastatic renal cell carcinoma (mRCC) using pooled data from France and Germany
العنوان: | 1460P IO-Synthesise RCC: Analysis of real-world (RW) health-related quality of life (HRQoL) outcomes with nivolumab for previously treated metastatic renal cell carcinoma (mRCC) using pooled data from France and Germany |
---|---|
المؤلفون: | Mouillet, G., Bedke, J., Albiges, L., Barthelemy, P., Escudier, B., Gruenwald, V., Ivanyi, P., Mueller-Huesmann, H., Vano, Y-A., von der Heyde, E., Ejzykowicz, F., Brellier, F., Herber, M., Quentric, C., Bennett, B.M., Nere, S., Autengruber, A., Thiery-Vuillemin, A., Grimm, M-O. |
المصدر: | In Annals of Oncology September 2022 33 Supplement 7:S1212-S1213 |
قاعدة البيانات: | ScienceDirect |
كن أول من يترك تعليقا!